Byetta May Help in Type 1 Diabetes, Too (CME/CE)
(MedPage Today) -- The GLP-1 agonist exenatide (Byetta) used in type 2 diabetes may have metabolic effects on patients with type 1 disease, researchers found.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Byetta | Cardiology | Cardiovascular | Diabetes | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | Heart